Stroke in China: advances and challenges in epidemiology, prevention, and management

The Lancet Neurology

Volumn 18, Issue 4, 2019, Pages 394-405

  Wu, Simiao ^a,u   Wu, Bo ^a,u   Liu, Ming ^a,u   Chen, Zhengming ^b,u   Wang, Wenzhi ^c,u   Anderson, Craig S ^g,h,i,u   Sandercock, Peter ^j,u   Wang, Yongjun ^d,u   Huang, Yining ^k,u   Cui, Liying ^l,u   Pu, Chuanqiang ^m,u   Jia, Jianping ^e,u   Zhang, Tong ^c,f,u   Liu, Xinfeng ^n,u   Zhang, Suming ^o,u   Xie, Peng ^p,u   Fan, Dongsheng ^q,r,u   Ji, Xunming ^e,u   Wong, Ka Sing Lawrence ^s,u   Wang, Longde ^t,u   Wei, Chenchen ^u   Wang, Yanan ^u   Cheng, Yajun ^u   Liu, Yunhai ^u   Li, Xin ^u   Dong, Qiang ^u   Zeng, Jinsheng ^u   Peng, Bin ^u   Xu, Yun ^u   Yang, Yi ^u   Wang, Yilong ^u   Zhao, Gang ^u   Wang, Wei ^u   Xu, Yuming ^u   Yang, Qingwu ^u   He, Zhiyi ^u   Wang, Shaoshi ^u   You, Chao ^u   Gao, Ying ^u   Zhou, Dong ^u   He, Li ^u   Li, Zixiao ^u   Yang, Jie ^u   Lei, Chunyan ^u   Zhao, Yuhua ^u   Liu, Junfeng ^u   Zhang, Shuting ^u   Tao, Wendan ^u   Hao, Zilong ^u   Wang, Deren ^u   Zhang, Shihong ^u   more..

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f CHINA REHABILITATION RESEARCH CENTER   (China)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

ⁱ ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^j UNIVERSITY OF EDINBURGH   (United Kingdom)

^k PEKING UNIVERSITY FIRST HOSPITAL   (China)

^l PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^m CHINESE PLA GENERAL HOSPITAL   (China)

ⁿ MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^o HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^p THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^q PEKING UNIVERSITY THIRD HOSPITAL   (China)

^r PEKING UNIVERSITY   (China)

^s CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^t Pharmacopoeia Commission of the People's Republic of China   (China)

^u NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHINA; CORONARY RISK; EPIDEMIOLOGICAL DATA; HIGH RISK POPULATION; HUMAN; MANAGED CARE; MULTICENTER STUDY (TOPIC); NEUROIMAGING; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SECONDARY ANALYSIS; SECONDARY PREVENTION; STROKE REHABILITATION; DISEASE MANAGEMENT; PREVALENCE; QUALITY ADJUSTED LIFE YEAR;

CHINA; DISEASE MANAGEMENT; HUMANS; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; STROKE;

EID: 85062907971     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(18)30500-3     Document Type: Review

References (102)

1. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390 (2017), 1151–1210.
2. Zhou, M, Wang, H, Zhu, J, et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387 (2016), 251–272.
3. Feigin, VL, Forouzanfar, MH, Krishnamurthi, R, et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 383 (2014), 245–255.
4. Liu, M, Wu, B, Wang, W-Z, Lee, L-M, Zhang, S-H, Kong, L-Z, Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol 6 (2007), 456–464.
5. Wang, W, Jiang, B, Sun, H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation 135 (2017), 759–771.
6. Guan, T, Ma, J, Li, M, et al. Rapid transitions in the epidemiology of stroke and its risk factors in China from 2002 to 2013. Neurology 89 (2017), 53–61.
7. Chen, Z, Peto, R, Zhou, M, et al. Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies. Lancet 386 (2015), 1447–1456.
8. Millwood, IY, Li, L, Smith, M, et al. Alcohol consumption in 0·5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates. Int J Epidemiol 42 (2013), 816–827.
9. Huo, Y, Li, J, Qin, X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA 313 (2015), 1325–1335.
10. He, J, Zhang, Y, Xu, T, et al. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. JAMA 311 (2014), 479–489.
11. Zhang, S, Wu, B, Liu, M, et al. Acupuncture efficacy on ischemic stroke recovery: multicenter randomized controlled trial in China. Stroke 46 (2015), 1301–1306.
12. Wang, Y, Wang, Y, Zhao, X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 369 (2013), 11–19.
13. GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet 391 (2018), 2236–2271.
14. Ministry of Health of People's Republic of China. National Health Services Survey, 1993–2013. http://www.moh.gov.cn/mohwsbwstjxxzx/s8211/list.shtml. (Accessed 30 November 2018)
15. National Health and Family Planning Commission of the People's Republic of China. China's Public Health Statistical Yearbooks 2004–2016. http://www.nhfpc.gov.cn/zwgkzt/tjnj/list.shtml. (Accessed 30 November 2018)
16. Feigin, VL, Krishnamurthi, RV, Parmar, P, et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990–2013: the GBD 2013 study. Neuroepidemiology 45 (2015), 161–176.
17. Li, Y, Yang, L, Wang, L, et al. Burden of hypertension in China: a nationally representative survey of 174,621 adults. Int J Cardiol 227 (2017), 516–523.
18. Wang, Z, Chen, Z, Zhang, L, et al. Status of hypertension in China: results from the China Hypertension Survey, 2012–2015. Circulation 137 (2018), 2344–2356.
19. Lu, Y, Wang, P, Zhou, T, et al. Comparison of prevalence, awareness, treatment, and control of cardiovascular risk factors in China and the United States. J Am Heart Assoc, 7, 2018, e007462.
20. Falaschetti, E, Mindell, J, Knott, C, Poulter, N, Hypertension management in England: a serial cross-sectional study from 1994 to 2011. Lancet 383 (2014), 1912–1919.
21. Pan, L, Yang, Z, Wu, Y, et al. The prevalence, awareness, treatment and control of dyslipidemia among adults in China. Atherosclerosis 248 (2016), 2–9.
22. Wang, L, Gao, P, Zhang, M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA 317 (2017), 2515–2523.
23. Wang, M, Luo, X, Xu, S, et al. Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013. Lancet Respir Med 7 (2019), 35–45.
24. Brauer, M, Freedman, G, Frostad, J, et al. Ambient air pollution exposure estimation for the Global Burden of Disease 2013. Environ Sci Technol 50 (2016), 79–88.
25. Yu, K, Qiu, G, Chan, K H, et al. Association of solid fuel use with risk of cardiovascular and all-cause mortality in rural China. JAMA 319 (2018), 1351–1361.
26. Luo, L, Jiang, J, Zhang, G, et al. Stroke mortality attributable to ambient particulate matter pollution from 1990 to 2015 in China: an age-period-cohort and spatial autocorrelation analysis. Int J Environ Res Public Health, 14, 2017, 772.
27. Li, Y, He, Y, Lai, J, et al. Dietary patterns are associated with stroke in Chinese adults. J Nutr 141 (2011), 1834–1839.
28. Wang, X, Wu, Y, Zhang, X, Zhang, M, Huang, G, Dietary changes over 25 years in Tianjin residents: findings from the 1986–1988, 2000–2004, and 2008–2011 Nutrition Surveys. Nutrients, 8, 2016, 62.
29. Anderson, CA, Appel, LJ, Okuda, N, et al. Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc 110 (2010), 736–745.
30. Stroke Prevention Project Committee. Programme of Stroke Screening and Intervention for High-risk Population. http://cnstroke.com/WebManage/InterveneProject/Index. (Accessed 30 November 2018)
31. Wang, D, Liu, J, Liu, M, Lu, C, Brainin, M, Zhang, J, Patterns of stroke between university hospitals and nonuniversity hospitals in mainland China: prospective multicentre hospital-based registry study. World Neurosurg 98 (2017), 258–265.
32. Wang, Y, Cui, L, Ji, X, et al. The China National Stroke Registry for patients with acute cerebrovascular events: design, rationale, and baseline patient characteristics. Int J Stroke 6 (2011), 355–361.
33. Wei, JW, Arima, H, Huang, Y, et al. Variation in the frequency of intracerebral haemorrhage and ischaemic stroke in China: a national, multicentre, hospital register study. Cerebrovasc Dis 29 (2010), 321–327.
34. He, W, Liu, Y, Feng, J, et al. The epidemiological characteristics of stroke in Hunan Province, China. Front Neurol, 9, 2018, 583.
35. Hao, Z, Liu, M, Li, W, et al. Basic characteristics and functional outcomes of 3123 consecutive patients in Chengdu stroke registry. Chin J Neurol 44 (2011), 826–831 (in Chinese).
36. Zhang, J, Huang, Y, Treatment of acute ischemic stroke in China. Chin J Neurol 42 (2009), 223–228 (in Chinese).
37. Chen, G, Wang, A, Zhao, X, et al. Frequency and risk factors of spontaneous hemorrhagic transformation following ischemic stroke on the initial brain CT or MRI: data from the China National Stroke Registry (CNSR). Neurol Res 38 (2016), 538–544.
38. Zhou, G, An, Z, Wang, J, Ning, X, Differences in the subtypes, risk factors, and 12-month outcome of ischemic stroke. J Apoplexy Nerv Dis 31 (2014), 625–627 (in Chinese).
39. Tian, D, Yang, Q, Dong, Q, Li, N, Yan, B, Fan, D, Trends in stroke subtypes and vascular risk factors in a stroke center in China over 10 years. Sci Rep, 8, 2018, 5037.
40. Ornello, R, Degan, D, Tiseo, C, et al. Distribution and temporal trends from 1993 to 2015 of ischemic stroke subtypes: a systematic review and meta-analysis. Stroke 49 (2018), 814–819.
41. Wu, B, Lin, S, Hao, Z, et al. Proportion, risk factors and outcome of lacunar infarction: a hospital-based study in a Chinese population. Cerebrovasc Dis 29 (2010), 181–217.
42. Lei, C, Wu, B, Liu, M, Tan, G, Zeng, Q, Pathogenesis and subtype of intracerebral haemorrhage (ICH) and ICH score determines prognosis. Curr Neurovasc Res 13 (2016), 244–248.
43. Yeh, SJ, Tang, SC, Tsai, LK, Jeng, JS, Pathogenetical subtypes of recurrent intracerebral hemorrhage: designations by SMASH-U classification system. Stroke 45 (2014), 2636–2642.
44. Meretoja, A, Strbian, D, Putaala, J, et al. SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke 43 (2012), 2592–2597.
45. O'Donnell, MJ, Chin, SL, Rangarajan, S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet 388 (2016), 761–775.
46. Chen, Z, Sandercock, P, Xie, JX, Peto, R, Collins, R, Liu, LS, Hospital management of acute ischemic stroke in China. J Stroke Cerebrovasc Dis 6 (1997), 361–367.
47. Li, Z, Wang, C, Zhao, X, et al. Substantial progress yet significant opportunity for improvement in stroke care in China. Stroke 47 (2016), 2843–2849.
48. Langhorne, P, O'Donnell, MJ, Chin, SL, et al. Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study. Lancet 391 (2018), 2019–2027.
49. Wang, Y, Li, Z, Zhao, X, et al. Effect of a multifaceted quality improvement intervention on hospital personnel adherence to performance measures in patients with acute ischemic stroke in China: a randomized clinical trial. JAMA 320 (2018), 245–254.
50. Wang, Y, Liao, X, Zhao, X, et al. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR). Stroke 42 (2011), 1658–1664.
51. Huang, Y, Wang, JG, Wei, JW, et al. Age and gender variations in the management of ischaemic stroke in China. Int J Stroke 5 (2010), 351–359.
52. Lin, S, Wu, B, Hao, ZL, et al. Characteristics, treatment and outcome of ischemic stroke with atrial fibrillation in a Chinese hospital-based stroke study. Cerebrovasc Dis 31 (2011), 419–426.
53. Hao, Z, Chang, X, Zhou, H, Lin, S, Liu, M, A cohort study of decompressive craniectomy for malignant middle cerebral artery infarction: a real-world experience in clinical practice. Medicine (Baltimore), 94, 2015, e1039.
54. Han, F, Zhai, FF, Wang, Q, et al. Prevalence and risk factors of cerebral small vessel disease in a Chinese population-based sample. J Stroke 20 (2018), 239–246.
55. Clarke, R, Du, H, Kurmi, O, et al. Burden of carotid artery atherosclerosis in Chinese adults: implications for future risk of cardiovascular diseases. Eur J Prev Cardiol 24 (2017), 647–656.
56. Chinese Stroke Society of the Chinese Society of Neurology. 2014 Chinese Guidelines for Secondary Prevention of Ischaemic Stroke and Transient Ischaemic Attack. Chin J Neurol 48 (2015), 258–273 (in Chinese).
57. Chinese Stroke Society of the Chinese Society of Neurology. 2014 Chinese Guidelines for Diagnosis and Treatment of Acute Ischaemic Stroke. Chin J Neurol 48 (2015), 246–257 (in Chinese).
58. Chinese Stroke Society of the Chinese Society of Neurology. 2014 Chinese Guideline for the Management of Patients with Intracerebral Haemorrhage. Chin J Neurol 48 (2015), 435–444 (in Chinese).
59. Chinese Stroke Society of the Chinese Society of Neurology. 2015 Chinese Guidelines of Primary Prevention of Cerebrovascular Diseases. Chin J Neurol 48 (2015), 629–643 (in Chinese).
60. Ru, X, Dai, H, Jiang, B, et al. Current situation of rehabilitation for stroke survivors living in community in three cities. Chin J Stroke 8 (2013), 255–260 (in Chinese).
61. Berkhemer, OA, Fransen, PS, Beumer, D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372 (2015), 11–20.
62. Campbell, BC, Mitchell, PJ, Kleinig, TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372 (2015), 1009–1018.
63. Goyal, M, Demchuk, AM, Menon, BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372 (2015), 1019–1030.
64. Jovin, TG, Chamorro, A, Cobo, E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 372 (2015), 2296–2306.
65. Saver, JL, Goyal, M, Bonafe, A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372 (2015), 2285–2295.
66. Jin, H, Zhu, S, Wei, JW, et al. Factors associated with prehospital delays in the presentation of acute stroke in urban China. Stroke 43 (2012), 362–370.
67. Jiang, B, Ru, X, Sun, H, et al. Pre-hospital delay and its associated factors in first-ever stroke registered in communities from three cities in China. Sci Rep, 6, 2016, 29795.
68. Zhao, J, Liu, R, Stroke 1-2-0: a rapid response programme for stroke in China. Lancet Neurol 16 (2017), 27–28.
69. Zhao, G, Huang, H, Yang, F, The progress of telestroke in China. Stroke Vasc Neurol 2 (2017), 168–171.
70. Thomalla, G, Simonsen, CZ, Boutitie, F, et al. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med 379 (2018), 611–622.
71. Nogueira, RG, Jadhav, AP, Haussen, DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 378 (2018), 11–21.
72. Albers, GW, Marks, MP, Kemp, S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 378 (2018), 708–718.
73. Wei, JW, Huang, Y, Wang, JG, et al. Current management of intracerebral haemorrhage in China: a national, multi-centre, hospital register study. BMC Neurol, 11, 2011, 16.
74. Chen, Y, Li, L, Zhang, Q, et al. Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China: China Kadoorie Biobank Study of 0·5 million people. Int J Cardiol 172 (2014), 88–95.
75. Yusuf, S, Islam, S, Chow, CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 378 (2011), 1231–1243.
76. Wei, JW, Wang, JG, Huang, Y, et al. Secondary prevention of ischemic stroke in urban China. Stroke 41 (2010), 967–974.
77. Tan, Y, Pan, Y, Liu, L, Wang, Y, Zhao, X, Wang, Y, One-year outcomes and secondary prevention in patients after acute minor stroke: results from the China National Stroke Registry. Neurol Res 39 (2017), 484–491.
78. Peng, B, Ni, J, Anderson, CS, et al. Implementation of a structured guideline-based program for the secondary prevention of ischemic stroke in China. Stroke 45 (2014), 515–519.
79. Wang, L, Ling, Y, Yang, H, et al. Fixed-dose combination treatment after stroke for secondary prevention in China: a national community-based study. Stroke 46 (2015), 1295–1300.
80. Wang, X, Fu, Q, Song, F, et al. Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: results from a national stroke screening survey. Int J Cardiol 271 (2018), 92–97.
81. Yang, X, Li, S, Zhao, X, et al. Atrial fibrillation is not uncommon among patients with ischemic stroke and transient ischemic stroke in China. BMC Neurol, 17, 2017, 207.
82. Gao, Q, Fu, X, Wei, JW, et al. Use of oral anticoagulation among stroke patients with atrial fibrillation in China: the ChinaQUEST (Quality Evaluation of Stroke Care and Treatment) Registry study. Int J Stroke 8 (2013), 150–154.
83. Li, SY, Zhao, XQ, Wang, CX, et al. One-year clinical prediction in Chinese ischemic stroke patients using the CHADS2 and CHA2DS2-VASc scores: the China National Stroke Registry. CNS Neurosci Ther 18 (2012), 988–993.
84. Yang, X, Li, Z, Zhao, X, et al. Use of warfarin at discharge among acute ischemic stroke patients with nonvalvular atrial fibrillation in China. Stroke 47 (2016), 464–470.
85. Guo, J, Guan, T, Fan, S, Chao, B, Wang, L, Liu, Y, Underuse of oral anticoagulants in patients with ischemic stroke and atrial fibrillation in China. Am J Cardiol 122 (2018), 2055–2061.
86. Wang, D, Liu, J, Hao, Z, et al. Antithrombotic therapy for ischaemic stroke patients with AF/RHD in West China daily practice. Neurol Res 37 (2015), 902–907.
87. van Asch, CJJ, Luitse, MJA, Rinkel, GJE, van der Tweel, I, Algra, A, Klijn, CJM, Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 9 (2010), 167–176.
88. Wang, LD, Report on stroke prevention and treatment. 2017, People's Medical Publishing House, Beijing.
89. Wang, Y, Zhao, X, Liu, L, et al. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study. Stroke 45 (2014), 663–669.
90. Miao, Z, Zhang, Y, Shuai, J, et al. Thirty-day outcome of a multicenter registry study of stenting for symptomatic intracranial artery stenosis in China. Stroke 46 (2015), 2822–2829.
91. Wang, Q, Pan, X, Qi, H, Li, A, Neng, W, An overview study and analysis of influencing factors on early stage rehabilitation for stroke patients in second-grade hospitals. Chin J Rehab 28 (2013), 120–122 (in Chinese).
92. Li, X, Xia, X, Wang, P, Zhang, S, Liu, M, Wang, L, Needs and rights awareness of stroke survivors and caregivers: a cross-sectional, single-centre questionnaire survey. BMJ Open, 7, 2017, e013210.
93. Zhang, Y, Reilly, KH, Tong, W, et al. Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. J Hypertens 26 (2008), 1446–1452.
94. Wang, Z, Li, J, Wang, C, et al. Gender differences in 1-year clinical characteristics and outcomes after stroke: results from the China National Stroke Registry. PLoS One, 8, 2013, e56459.
95. Wei, JW, Heeley, EL, Wang, JG, et al. Comparison of recovery patterns and prognostic indicators for ischemic and hemorrhagic stroke in China: the ChinaQUEST (Quality Evaluation of Stroke Care and Treatment) Registry study. Stroke 41 (2010), 1877–1883.
96. Shi, GM, Zhang, YD, Geng, C, et al. Profile and 1-year outcome of ischemic stroke in east China: Nanjing First Hospital Stroke Registry. J Stroke Cerebrovasc Dis 25 (2016), 49–56.
97. Gu, HQ, Li, ZX, Zhao, XQ, et al. Insurance status and 1-year outcomes of stroke and transient ischaemic attack: a registry-based cohort study in China. BMJ Open, 8, 2018, e021334.
98. Wu, S, Yuan, R, Xiong, Y, Zhang, S, Wu, B, Liu, M, Clinical features, management and outcomes of severe ischaemic stroke in tertiary hospitals in China: protocol for a prospective multicentre registry-based observational study. BMJ Open, 8, 2018, e024900.
99. Zhou, J, Zhang, Y, Arima, H, et al. Sex differences in clinical characteristics and outcomes after intracerebral haemorrhage: results from a 12-month prospective stroke registry in Nanjing, China. BMC Neurol, 14, 2014, 172.
100. Wang, WJ, Lu, JJ, Wang, YJ, et al. Clinical characteristics, management, and functional outcomes in Chinese patients within the first year after intracerebral hemorrhage: analysis from China National Stroke Registry. CNS Neurosci Ther 18 (2012), 773–780.
101. Liu, J, Wang, D, Yuan, R, Xiong, Y, Liu, M, Prognosis of 908 patients with intracerebral hemorrhage in Chengdu, southwest of China. Int J Neurosci 127 (2017), 586–591.
102. Luengo-Fernandez, R, Paul, NL, Gray, AM, et al. Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the Oxford Vascular Study. Stroke 44 (2013), 2854–2861.